LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics

June 12, 2023
Exciting findings reveal a strong association between high LAG-3 expression and other immune checkpoints like PD-L1, PD-1 and CTLA-4. High tumor mutation burden (TMB) also correlates with LAG-3 expression, a marker for immunotherapy response. Explore the potential of LAG-3 as a resistance marker and immunotherapy target.  View the Graphical Summary      

Published in: Cancer Medicine